Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children

Journal of Clinical Laboratory Analysis

Volumn 31, Issue 6, 2017, Pages

  Franěk, Tomáš ^a   Kotaška, Karel ^a   Průša, Richard ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

cerebrospinal fluid; children; electrothermal atomic absorption spectroscopy; manganese; selenium; values

Indexed keywords

MANGANESE; SELENIUM;

ADOLESCENT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; HOSPITALIZED CHILD; HUMAN; LEUKEMIA; LYMPHOMA; MALE; NEUROLOGIC DISEASE; TRAUMATIC BRAIN INJURY; BRAIN DISEASE; INFANT; LIMIT OF DETECTION; NEOPLASM; PRESCHOOL CHILD; STATISTICAL MODEL;

ADOLESCENT; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; INFANT; LIMIT OF DETECTION; LINEAR MODELS; MALE; MANGANESE; NEOPLASMS; SELENIUM; SPECTROPHOTOMETRY, ATOMIC;

EID: 85013236813     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22122     Document Type: Article

References (11)

1. Gerhardsson L, Lundh T, Minthon L, Londos E. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008;25:508–515.
2. Alimonti A, Bocca B, Pino A, Ruggieri F, Forte G, Sancesario G. Elemental profile of cerebrospinal fluid in patients with Parkinson's disease. J Trace Elem Med Biol. 2007;21:234–241.
3. Forte G, Bocca B, Senofonte O, et al. Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. J Neural Transm (Vienna). 2004;111:1031–1040.
4. Gellein K, Skogholt JH, Aaseth J, et al. Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease. J Neurol Sci. 2008;266:70–78.
5. Tondo M, Moreno J, Casado M, et al. Selenium concentration in cerebrospinal fluid samples from a paediatric population. Neurochem Res. 2010;35:1290–1293.
6. Qureshi GA, Qureshi AA, Memon SA, Parvez SH. Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy. J Neural Transm. 2006;Suppl:229–236.
7. Aguilar MV, Jimenez-Jimenez FJ, Molina JA, et al. Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease. J Neural Transm (Vienna). 1998;105:1245–1251.
8. Speziali M, Di Casa M, editors. Minor and Trace Elements in Cerebrospinal Fluid of Parkinson's Patients – Suggestions After a Critical Review of the Analytical Data. Rijeka: InTech; 2011:149–164.
9. Gazzaniga GC, Ferraro B, Camerlingo M, Casto L, Viscardi M, Mamoli A. A case control study of CSF copper, iron and manganese in Parkinson disease. Ital J Neurol Sci. 1992;13:239–243.
10. El-Yazigi A, Al-Saleh I, Al-Mefty O. Concentrations of Ag, Al, Au, Bi, Cd, Cu, Pb, Sb, and Se in cerebrospinal fluid of patients with cerebral neoplasms. Clin Chem. 1984;30:1358–1360.
11. Michalke B, Nischwitz V. Review on metal speciation analysis in cerebrospinal fluid-current methods and results: a review. Anal Chim Acta. 2010;682:23–36.